BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 18084874)

  • 1. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
    Ushiroyama T; Ikeda A; Sakuma K; Ueki M
    J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance considerations with hormone replacement therapy.
    Karakoç B; Erenus M
    Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
    Gambrell RD; Natrajan PK
    Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuation of hormone replacement therapy in Slovenia: a prospective, randomized, controlled trial--1-year follow-up.
    Franić D; Verdenik I; Meden-Vrtovec H; Svab I
    Maturitas; 2006 May; 54(2):110-8. PubMed ID: 16293377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance to hormone replacement therapy.
    Rozenberg S; Vandromme J; Kroll M; Pastijn A; Liebens F
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():23-32. PubMed ID: 7581586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with hormone replacement therapy in postmenopausal Sicilian women.
    Corrado F; D'Anna R; Caputo F; Cannata ML; Zoccali MG; Cancellieri F
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):225-8. PubMed ID: 15653208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention.
    Boraz MA; Simkin-Silverman LR; Wing RR; Meilahn EN; Kuller LH
    Prev Med; 2001 Aug; 33(2 Pt 1):108-14. PubMed ID: 11493043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
    Kwee SH; Tan HH; Marsman A; Wauters C
    Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy.
    Griffiths F; Convery B
    Br J Gen Pract; 1995 Jul; 45(396):355-8. PubMed ID: 7612339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reflections on compliance in menopause hormone replacement therapy].
    Berthet J; Tabaste JL; Vendittelli F
    Rev Fr Gynecol Obstet; 1995 Dec; 90(12):548-51. PubMed ID: 8677410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.